Yiwu International perspective pharmaceutical industry

Huayi medicine is not the first time out of the country up. Early in 2011, the Huayi medicine ciprofloxacin hydrochloride independent research team had to break into the US market through the FDA certification, the company through the EU CEP (European Pharmacopoeia Certificate of Suitability) certified API has reached five kinds. Huayi ESTEVEQUIMICA medicine is a joint venture with Spain's high-tech pharmaceutical company, was recognized in 2006 Torch Program Center for the National Torch Plan Key High-tech enterprises. Yiwu market They take the initiative to "go out", to participate in international cutting-edge research and development of new drug intermediates pharmaceutical research and development organization, to have the vision to seize the international high-end market.

As we all know, new drug research and development with investment, long cycle, high risks. In developed countries, pharmaceutical companies, R & D investment to account for more than 10% of the company's total sales, but according to incomplete statistics, the majority of the domestic pharmaceutical industry R & D investment is quite low. "Our company's R & D investment ratio has been maintained at 5% -10%, based on 2014 sales as the base, the actual R & D investment last year amounted to more than 1300 yuan." Huayi Pharmaceutical general manager, yiwu city chief engineer said that now from the central and local governments have put a lot of food to encourage the development of bio-pharmaceutical health industry policy, the domestic drug development environment has been greatly improved. 2014, Huayi Pharmaceutical established a medicine plant, fully into the Chinese medicine field. "Pieces of Chinese medicine will be the focus of our future development." he said.

said that in order to reduce pollution on the surrounding environment and enhance the value and core competitiveness of products, currently Huayi medicine strive toward the production of finished formulations transition from production of raw materials medicine, so more environmentally friendly, but also make their products directly to consumers, Yiwu Wholesale Market so that a higher value product. It is understood that Huayi Pharmaceutical R & D team has completed applies to the digestive system, nine kinds of formulations developed nervous system, type 2 diabetes, cancer, antibiotics, antivirals, and other six areas, has now entered the stage to declare review.